IMPAACT 1092: Phase IV Evaluation Of The Steady State Pharmacokinetics Of Zidovudine, Lamivudine, and Lopinavir/Ritonavir in Severely Malnourished HIV-1-Infected Children
Phase of Trial: Phase IV
Latest Information Update: 23 Jan 2018
At a glance
- Drugs Lamivudine (Primary) ; Lopinavir/ritonavir (Primary) ; Zidovudine (Primary)
- Indications HIV-1 infections
- Focus Adverse reactions; Pharmacokinetics
- 17 Jan 2018 Status changed from active, no longer recruiting to completed.
- 12 May 2017 Planned End Date changed from 1 Nov 2017 to 1 Dec 2017.
- 12 May 2017 Planned primary completion date changed from 1 Mar 2017 to 1 Jun 2017.